Sarah A Weiss

In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target

John G. Doench, David E. Root, David E. Fisher, 2017, Nature.

Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

F. Hodi, W. Haining, K. Yates, 2019, Nature Immunology.

Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8+ T cells.

G. Freeman, A. Sharpe, M. Haigis, 2022, Cell metabolism.